Intermediate Coronary Artery Disease Risk Patients: Reclassification With Coronary Calcium Scoring or Statin Therapy?

Authors

  • Dimitris Tsilakis Evagelismos General Hospital, Athens

DOI:

https://doi.org/10.2015/hc.v5i1%20Sup.369

Abstract

Cardiovascular diseases continue to be the leading cause of death in the developed world. A better risk prediction is definitely needed to lower morbidity and mortality by primary prevention measures. The effects of Framingham risk score calculation can be improved by both hsCRP measurement and coronary artery calcium scoring. More trials are needed in order to further estimate and compare their relative efficacy in improving risk estimation especially in the intermediate risk patients who need it more.

Author Biography

Dimitris Tsilakis, Evagelismos General Hospital, Athens

Specialty: Cardiology

Downloads

Issue

Vol. 5 No. 1 Sup (2010)

Section

Athens Cardiology Update 2010

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).